Rhinitis: all 1,101 studies

Page 9 of 12. Open to participants first (63), then studies with results posted, then the rest; newest registration first within each.

• Safety, Efficacy and Pharmacokinetic Study of Allegra in Pediatric Patients With Perennial Allergic Rhinitis (PAR)CompletedNCT01244217Phase 2/3
• Study of ACT-129968 in Adult Patients With Seasonal Allergic RhinitisCompletedNCT01241214Phase 2
• Comparison of Different Up-dosing Schedules With OsirisTerminatedNCT01240954Phase 2
• Topical Allstate and Nasal Allergen ChallengeWithdrawnNCT01231724Phase 3
• Vienna Challenge Chamber Study Using RV658 in Subjects With Allergic RhinitisCompletedNCT01230619Phase 2
• Montelukast and Nasal Epithelial Cell Inflammatory Responses in Asthma and RhinitisStatus unknownNCT01230437
• Effectiveness of Two Preparations of Loratadine + Pseudoephedrine in Patients With Perennial Allergic Rhinitis.CompletedNCT01228630Phase 3
• Neuro-immunological Analysis of Idiopathic Rhinitis Patients and Controls Treated With Capsaicin.CompletedNCT01223820Phase 4
• Single Rising Dose (SRD), Multiple Rising Dose (MRD) Study of BI 671800 in Healthy Asian VolunteersCompletedNCT01216384Phase 1
• A Comparison of Patients on AVAMYS ® Versus NASONEX (A Trade Mark of Schering Corporation) and FLIXONASE ® on Key Health Outcome MeasuresCompletedNCT01199757
• Study to Evaluate the Efficacy and Safety of Fixed Dose Combination of Diphenhydramine + Pseudoephedrine + Dropropizine in the Control of Cough and the Relief of Nasal Symptoms, Suffering From Non-productive Cough and Acute RhinitisWithdrawnNCT01199497Phase 3
• Single Dose Pharmacokinetics of Intranasal Fluticasone Delivered by a Fixed Combination With Azelastine (MP29 02) in Comparison to Two Different Fluticasone Nasal SpraysCompletedNCT01194622Phase 1
• Eosinophil Markers and Development of Disease in Allergic RhinitisCompletedNCT01192386
• Single Dose Pharmacokinetics of Intranasal Azelastine Delivered by a Fixed Combination With Fluticasone in Comparison to Azelastine Nasal SpraysCompletedNCT01190852Phase 1
• Repeated Nasal Challenge in Skin Prick-puncture Negative and Intradermal Positive Dust Mite Allergic Rhinitis PatientsCompletedNCT01179282Not applicable
• Evaluation of Efficacy and Safety in Control Cough and the Relief of Nasal Symptoms in Children 2-12 Years Old,Suffering From Cough and Acute RhinitisWithdrawnNCT01177852Phase 3
• Optimal Concentration of Dermatophagoides Pteronyssinus (Dp) Allergen Extract for Skin Prick Test (SPT) of Thai PopulationStatus unknownNCT01172613
• Clinical Trial of STAHIST in Seasonal Allergic Rhinitis (SAR) SubjectsCompletedNCT01171664Phase 2
• A Study to Investigate the Safety, Tolerability, and Pharmacokinetics of MEMP1972A in Patients With Allergic RhinitisCompletedNCT01160861Phase 1
• A Study of RO4989991 in Patients With Allergic RhinitisCompletedNCT01152619Phase 1
• Effect of a Probiotic on Grass Pollen Allergic Rhinitis SubjectsCompletedNCT01150253Not applicable
• Dose Finding Study for Depigoid Birch: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-AsthmaCompletedNCT01144429Phase 2
• Theophylline in RhinitisCompletedNCT01132781Phase 2
• Efficacy Study for the Symptomatic Treatment of Perennial Allergic Rhinitis With a 1 Year Safety ExtensionCompletedNCT01127620Phase 3
• Sublingual Immunotherapy In Alternaria-Induced RhinitisCompletedNCT01127035Phase 4
• Seasonal Allergic Rhinitis StudyCompletedNCT01123252Phase 2
• the Efficacy and Safety of Probiotics eN-Lac® Capsules of Children With Perennial Allergic RhinitisCompletedNCT01116778Phase 3
• Efficacy of Allergen Immunotherapy for Allergic Rhinitis in ThaisCompletedNCT01115595Phase 4
• Genetics of the Early and Late Response to Allergen ChallengeCompletedNCT01113697
• Assessment of Oxidative Stress Markers in the Upper and Lower Airways of Atopic Children Treated With Nebulized BeclomethasoneCompletedNCT01113489Phase 3
• Repeat Dose Nasal Allergen ChallengeStatus unknownNCT01110837Not applicable
• A Phase III Efficacy Study of the Symptomatic Treatment of Seasonal Allergic Rhinitis With BilastineCompletedNCT01108783Phase 3
• Validation of Proteomic Analyses for Allergic Asthma and RhinitisCompletedNCT01104012
• A Cross Over Study to Compare the Effect of Combined Treatment With QAV680 and CetirizineCompletedNCT01103050Phase 2
• Effect Of Probiotic Lactobacillus Paracasei Lp-33 For The Management Of Rhinitis In People Sensitized To AllergensCompletedNCT01096615Phase 3
• Pilot Study for Cell Based Therapies in Patients With AsthmaCompletedNCT01087515Not applicable
• Prevalence of Asthma and Rhinitis Symptoms Among Secondary School Students in Saudi ArabiaStatus unknownNCT01085916
• Changes in Specific Immunoglobulin and Blood Basophil Activity During Subcutaneous Immunotherapy in Allergic RhinitisCompletedNCT01085526Not applicable
• Flixonase Safety in Patients With Allergic Rhinitis (AR)CompletedNCT01077609
• An Allergen BioCube (ABC) Study Evaluating the Onset of Action of Fluticasone Furoate Nasal Spray and Olopatadine Nasal Spray Compared to PlaceboWithdrawnNCT01076439Phase 4
• The Development of Allergic Rhinitis in Children Previously Diagnosed as Nonallergic RhinitisCompletedNCT01068808
• Study to Investigate Effects of CAL-263 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental ChamberCompletedNCT01066611Phase 1
• A Study To Explore The Effect On Inflammatory Markers After Nasal Allergen Challenge In Subjects With Seasonal Allergic Rhinitis And The Effect Of A Single Dose Of Ibuprofen Or Fluticasone Propionate On The Allergen Response.CompletedNCT01064726Phase 1
• Cosalin® Monotherapy Versus Cosalin® and Xarlin® Combination TherapyStatus unknownNCT01062139Phase 4
• Grazax Asthma PreventionCompletedNCT01061203Phase 3
• PURETHAL Grasses Rush StudyCompletedNCT01059266Phase 4
• Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic RhinitisWithdrawnNCT01055756Phase 3
• A Randomized Study of Temperature-controlled and Bipolar Radiofrequency for Inferior Turbinate ReductionCompletedNCT01054521Not applicable
• A Single and Multiple Dose Study to Explore the Safety of JNJ-38224342 in Healthy Patients and Patients With Seasonal AllergiesCompletedNCT01054352Phase 1
• Assessment of Sublingual Immunotherapy in Children Allergic to House Dust MitesStatus unknownNCT01052610Phase 4
• The Effect Of PF-03654764 +/- Allegra On Symptoms Of Allergic RhinitisCompletedNCT01033396Phase 2
• Management of Allergic Rhinitis Patients With Nasal Steroids and NeilMed® Sinus Rinse™ System With Isotonic SalineCompletedNCT01030146Not applicable
• Non-inferiority, Open-label, Multicenter and Randomized Clinical Trial About the Treatment of Mild to Moderate Persistent Allergic RhinitisCompletedNCT01022047Phase 3
• A Study to Determine the Capacity of VAK694 When Combined With Allergen Immunotherapy to Bring About Specific Immune ToleranceCompletedNCT01018693Phase 2
• Safety and Efficacy Study With Allergen Extracts of House Dust Mites for Specific Sublingual ImmunotherapyStatus unknownNCT01014325Phase 3
• Evaluation of Efficacy and Safety of Specific Immunotherapy With Modified Allergen Extracts of House Dust MitesStatus unknownNCT01013116Phase 3
• Efficacy and Safety of Sublingual Immunotherapy (SLIT)Status unknownNCT01012882Phase 3
• A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen ExtractsStatus unknownNCT01012752Phase 3
• Efficacy and Safety of Specific Immunotherapy With CLUSTOID Grass PollenCompletedNCT01012531Phase 3
• The Effect of Levocetirizine on Inflammatory Mediators in DermatographismTerminatedNCT01008592
• Study of AHIST in Seasonal Allergic Rhinitis PatientsWithdrawnNCT01008397Phase 1
• Randomized, Placebo Controlled, Crossover Study in an Environmental Challenge Chamber to Assess Safety & Efficacy of Three Oral Doses of BI 671800 Versus Fluticasone Propionate and Montelukast in Sensitive Seasonal Allergic Rhinitis Patients Out of SeasonCompletedNCT01007721Phase 2
• Regulatory AVAMYS Nasal Spray PMSCompletedNCT01001130
• 3-D Visualization of the Anti-Obstructive Effect of LevocetirizineCompletedNCT01000792Phase 3
• A Study Comparing the Bioequivalence of Triamcinolone Acetonide Aqueous Nasal Spray (Apotex, Inc.) to That of Nasacort® AQ Nasal Spray (Sanofi-Aventis Pharmaceutical Products, Inc.) In the Treatment of Seasonal Allergic RhinitisCompletedNCT00987233Phase 3
• Study With High Dose PURETHAL Mites in Allergic Rhinitis/Rhinoconjunctivitis PatientsCompletedNCT00973453Phase 2
• Validation of the Rhinitis Control Scoring System (RCSS)SuspendedNCT00967967Not applicable
• Efficacy & Safety of Loratadine-Betamethasone Oral Solution for Treatment of Severe Perennial Allergic Rhinitis in Children (Study P03428)CompletedNCT00963573Phase 4
• Evaluation of Different Disease Control Indices in Children With Asthma and RhinitisStatus unknownNCT00952835
• Compare Captisol-Enabled (CE) Budesonide + Azelastine Nasal Solution and Rhinocort Aqua + Astelin in an Environmental Exposure Chamber (EEC) Study of Allergic RhinitisCompletedNCT00940953Phase 2
• Compare CE-Budesonide Nasal Solution & Rhinocort Aqua in an EEC Study of ARCompletedNCT00938613Phase 2
• SUBLIVAC® Birch PROBE StudyCompletedNCT00932607Phase 2
• Clinical Trial of STAHIST in Seasonal Allergic Rhinitis PatientsCompletedNCT00932256Phase 1
• Safety, Tolerability and Pharmacokinetics of Multiple Doses of VAK694 in Atopic Subjects With Seasonal RhinitisCompletedNCT00929968Phase 2
• DSP-3025 Study of Healthy Male Volunteers and Seasonal Allergic Rhinitis Male Patients Out of SeasonCompletedNCT00925678Phase 1
• Glycyphagus Domesticus Allergen Extract. Determination of the in Vivo Biological Activity in Histamine Equivalent Units (HEP).CompletedNCT00917488Phase 2
• The Effect of Nasal Carbon Dioxide (CO2) in the Symptomatic Treatment of Seasonal Allergic RhinitisCompletedNCT00917111Phase 2
• The Effect of Nasal Carbon Dioxide (CO2) Used As-Needed in the Symptomatic Treatment of Seasonal Allergic RhinitisCompletedNCT00917020Phase 2
• Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Grass PollenCompletedNCT00916422Phase 3
• Diesel Exhaust Particles and Leukotriene ProductionWithdrawnNCT00915447
• Intranasal SB-705498 in Healthy VolunteersCompletedNCT00907933Phase 1
• Nasonex® Nasal Suspension 50 μg Long-term Designated Drug Use Investigation (Study P05876)CompletedNCT00903721
• Steroid Sparing Effect of Nasal Corticosteroid In Asthma And RhinitisCompletedNCT00903227Phase 4
• Study of rBet v1 TabletsCompletedNCT00901914Phase 2
• Levocetirizine Effect on Nasal Nitric Oxide and Nasal Eosinophils in Subjects With Perennial Allergic RhinitisCompletedNCT00894231Phase 4
• Safety and Tolerability Study of rBet v1 SLIT TabletsCompletedNCT00889460Phase 1
• Comparison of the Effects of Desloratadine and Placebo in the Relief of Nasal Symptom Scores in Subjects With Seasonal Allergic Rhinitis to Cypress Pollen (Study P02836)CompletedNCT00867191Phase 4
• MOA Study of Ze 339 in Seasonal Allergic RhinitisCompletedNCT00862225Phase 2
• Study on Pharmacodynamic Parameter and Tolerability With Subcutaneous Immunotherapy in Grass Pollen Allergic PatientsCompletedNCT00857779Phase 2
• Preventing Tolerance to Oxymetazoline in Allergic RhinitisWithdrawnNCT00846326Phase 4
• Azelastine Fluticasone Combination vs. FluticasoneWithdrawnNCT00845598Phase 4
• Effect of a 10,000 EU Dose of Endotoxin in Allergic and Mildly Asthmatic AdultsCompletedNCT00839189Phase 1
• Study to Investigate Effects of CAL-101 in Subjects With Allergic Rhinitis Exposed to Allergen in an Environmental ChamberCompletedNCT00836914Phase 1
• Assessment of Intranasal Steroids in Allergic Rhinitis When Used Alone or in Combination With an Oral Antihistamine (Study P03270)CompletedNCT00834119Phase 4
• Gore Tex Implants in the Treatment of Atrophic RhinitisSuspendedNCT00832403
• Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Olea Europaea PollenCompletedNCT00831025Phase 3
• Influence of Probiotics on Atopy With Focus on Respiratory Allergic Diseases- Follow-up to 7 YearsCompletedNCT00826189
• Comparative Study of Sinol and Sinol-M in Patients With Congestion Due to Allergic RhinitisStatus unknownNCT00825656Phase 4
• Allergen Challenge Chamber Study With Single Dose Intranasal GSK1004723 Compared With PlaceboCompletedNCT00824356Phase 2
• Effectiveness of Individualized Homeopathic Treatment in Perennial Allergic RhinitisCompletedNCT00822406Phase 4

← Rhinitis overview